Role Description
The Sr. Principal Medical Development Director, MD will be responsible for clinical and translational leadership in the development and execution of the company’s oncology strategies; including, but not limited to, the design and implementation of next-generation sequencing (NGS) based assays focused on the development, validation, and regulatory approval of diagnostic tests designed to help determine the most appropriate therapies for patients, monitor therapy effectiveness, and detect the presence of residual disease.
-
Develop the overall vision and strategy for one or more specific Exact Sciences’ Precision Oncology (PO) products, including, but not limited to, the Oncotype DX recurrence score, radiation score, and colon recurrence score; OncoExTra and therapy selection portfolio; and the molecular residual disease (MRD) liquid biopsy portfolio.
-
Identify opportunities to expand indications for existing Exact Sciences’ PO products and new products within the pharma space.
-
Collaborate with Exact Sciences’ cross-functional team members from the research and development, pipeline, and commercial organizations to participate in and provide medical expertise to the formulation of commercialization strategy and the creation of product profiles for new products and services.
-
Participate as the medical monitor on study teams and lead the development of clinical protocols required to support product development, validation, and commercialization.
-
Engage with medical leaders within precision and molecular, medical and surgical and radiation oncology to gain a greater understanding of key clinical questions in patient management.
-
Accountable for scientific presentations and publications generated as a result of PO product development collaborations.
-
Provide oncology expertise and clinical insight for cross-functional teams at Exact Sciences throughout the lifecycle of practice-changing genomic tests and services.
-
Engage with colleagues in the medical organization to drive continuous improvement of team leadership practices.
-
Create an innovative and proactive approach to identify pharma partners for new product opportunities and indication expansion of existing products.
-
Apply strong analytical skills.
-
Apply strong communication skills; ability to create and maintain open, clear, and collaborative communication with internal stakeholders, senior management, external partners and customers, and key opinion leaders.
-
Ability to build and lead internal and external collaborations.
-
Ability to integrate and apply feedback in a professional manner.
-
Ability to prioritize and drive results with a high emphasis on quality.
-
Ability to excel and work effectively in a cross-functional team environment.
-
Uphold company mission and values through accountability, innovation, integrity, quality, and teamwork.
-
Support and comply with the company’s Quality Management System policies and procedures.
-
Maintain regular and reliable attendance.
-
Ability to act with an inclusion mindset and model these behaviors for the organization.
-
Ability to work on a mobile device, tablet, or in front of a computer screen and/or perform typing for approximately 90% of a typical working day.
-
Ability to travel up to 30% of working time away from work location, may include overnight/weekend travel.
Qualifications
-
M.D., D.O., in a related field as outlined in the essential duties.
-
Completion of fellowship training or equivalent in oncology.
-
Demonstrated expertise in molecular oncology.
-
Demonstrated ability to lead cross-functional internal and external teams of professionals focused on complex, multi-faceted projects.
-
Familiarity with laboratory analytical process development and biostatistics.
-
Demonstrated ability to perform the essential duties of the position with or without accommodation.
-
Authorization to work in the United States without sponsorship.
Requirements
-
2+ years of experience in healthcare.
-
Experience in oncology within the pharmaceutical or biotech industry with an emphasis on clinical or translational research.
-
Experience working with checkpoint inhibitor therapies.
-
Experience in the development of new oncology therapeutics and molecular diagnostics.
-
Strong knowledge of FDA and Ex-U.S. regulatory documentation and processes.
Benefits
-
The base pay for this position is $149,300.00 – $298,700.00.
-
In specific locations, the pay range may vary from the range posted.
Company Description
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries.